ArrowMark Colorado Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,534	Closed	-$223K	–	334
2020 Q3	$223K	Hold	1,534	–	–	﹤0.01%	325
2020 Q2	$227K	Sell	1,534 -1,967	-56%	-$265K	﹤0.01%	291
2020 Q1	$381K	Sell	3,501 -1,076	-24%	-$124K	0.01%	281
2019 Q4	$527K	Hold	4,577	–	–	﹤0.01%	289
2019 Q3	$368K	Sell	4,577 -12,475	-73%	-$987K	﹤0.01%	297
2019 Q2	$1.24M	Buy	17,052 +29	+0.2%	+$2.23K	0.01%	266
2019 Q1	$1.59M	Sell	17,023 -17,921	-51%	-$1.5M	0.02%	255
2018 Q4	$2.55M	Hold	34,944	–	–	0.03%	254
2018 Q3	$3.06M	Hold	34,944	–	–	0.03%	262
2018 Q2	$3.44M	Sell	34,944 -1,223	-3%	-$121K	0.03%	252
2018 Q1	$4.31M	Sell	36,167 -272,872	-88%	-$35.2M	0.04%	225
2017 Q4	$39.3M	Sell	309,039 -194,850	-39%	-$24.5M	0.4%	85
2017 Q3	$59.2M	Sell	503,889 -34,400	-6%	-$2.94M	0.67%	50
2017 Q2	$42.9M	Sell	538,289 -67,854	-11%	-$4.34M	0.53%	69
2017 Q1	$31.1M	Sell	606,143 -86,593	-13%	-$4M	0.42%	84
2016 Q4	$25.9M	Buy	692,736 +301,877	+77%	+$12.6M	0.41%	82
2016 Q3	$26.5M	Buy	390,859 +19,309	+5%	+$1.36M	0.48%	73
2016 Q2	$20.6M	Buy	371,550 +60,977	+20%	+$3.84M	0.42%	84
2016 Q1	$19.5M	Buy	310,573 +133,891	+76%	+$8.9M	0.43%	81
2015 Q4	$16.6M	Buy	176,682 +159,081	+904%	+$14.7M	0.45%	74
2015 Q3	$1.41M	Buy	17,601 +6,286	+56%	+$698K	0.04%	211
2015 Q2	$1.36M	Hold	11,315	–	–	0.03%	223
2015 Q1	$1.18M	Sell	11,315 -159,092	-93%	-$16.1M	0.03%	221
2014 Q4	$16.5M	Sell	170,407 -51,533	-23%	-$4.77M	0.42%	72
2014 Q3	$17.3M	Sell	221,940 -38,374	-15%	-$2.48M	0.48%	69
2014 Q2	$16.4M	Buy	260,314 +129,747	+99%	+$7.71M	0.47%	79
2014 Q1	$8.77M	Sell	130,567 -1,412	-1%	-$109K	0.28%	123
2013 Q4	$8.49M	Buy	131,979 +96,979	+277%	+$5.79M	0.26%	128
2013 Q3	$2.24M	Sell	35,000 -8,400	-19%	-$419K	0.07%	177
2013 Q2	$1.34M	Buy	+43,400	New	+$1.15M	0.36%	60